Vitamin C linked to fewer deaths in blood disorder trial
Vitamin C may do more than support the immune system. In a phase 2 trial of people with precancerous or low risk blood cancers, daily vitamin C did not slow abnormal cell growth, but it was linked to favorable changes in inflammation and fewer serious complications. An exploratory follow up also found fewer deaths among participants taking vitamin C than among those receiving placebo.
We haven't written up this one. ScienceDaily has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- Vitamin C linked to fewer deaths in blood disorder trial sciencedaily.com
